Patents by Inventor Max Wilkinson

Max Wilkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260008827
    Abstract: Systems and methods for targeted gene modification, targeted insertion, perturbation of gene transcripts, and nucleic acid editing. Novel nucleic acid targeting systems comprise components of CRISPR systems and non-LTR retrotransposon elements.
    Type: Application
    Filed: September 19, 2025
    Publication date: January 8, 2026
    Inventors: Feng Zhang, Max Wilkinson, Chris Frangieh
  • Publication number: 20250339554
    Abstract: Provided herein are compositions, systems, and methods for delivering cargo to a target cell. The compositions, systems, and methods comprise one or more polynucleotides encoding one or more LTR retroelement polypeptides for forming a delivery vesicle and one or more capture moieties for packaging a cargo within the delivery vesicle. The one or more LTR retroelement polypeptides for forming a delivery vesicle may comprise two or more of an LTR retroelement gag protein, a retroelement envelope protein, an LTR retroelement reverse transcriptase, or a combination thereof. The LTR retroelement polypeptide alone, the LTR retroelement envelope protein alone, or both the LTR retroelement-derived polypeptide and LTR retroelement envelope protein may be endogenous. In some embodiments the LTR-retroelement-derived polypeptide is a PNMA polypeptide.
    Type: Application
    Filed: January 4, 2023
    Publication date: November 6, 2025
    Inventors: Feng Zhang, Victoria Madigan, Yugang Zhang, Rumya Raghavan, Elena Puccio, Max Wilkinson, Guilhem Faure
  • Publication number: 20250243471
    Abstract: Described in several example embodiments herein are engineered programmable pattern recognition compositions and uses thereof. In an embodiment, the engineered protein contains an NTPase of a Signal Transduction ATPases with Numerous-associated Domains (STAND) superfamily (STAND NTPase), comprising a pathogen-associated molecular pattern (PAMP) recognition activity, wherein the STAND NTPase and the PAMP recognition activity are derived from the same or different prokaryotes.
    Type: Application
    Filed: January 29, 2025
    Publication date: July 31, 2025
    Inventors: Feng Zhang, Alex Gao, Max Wilkinson, Jonathan Strecker
  • Publication number: 20250064976
    Abstract: Described herein are engineered paraneoplastic Ma protein (PNMA) capable of forming a capsid. In some embodiments, the engineered PNMA proteins comprise one or more modifications that enhance binding or loading of a cargo into the capsid, one or more modifications that modify cell-specificity of the capsid, one or more modifications that enhance intracellular delivery of the capsid, or a combination thereof. Also described herein are delivery systems comprising capsids comprising an engineered PNMA protein and a cargo.
    Type: Application
    Filed: November 15, 2024
    Publication date: February 27, 2025
    Inventors: Feng Zhang, Victoria Madigan, Yugang Zhang, Rumya Raghavan, Max Wilkinson, Guilhem Faure, Rhiannon Macrae